Emine Esra ERGÜL

Dr. Emine Esra ERGÜL

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
Emine Esra ERGÜLEmine Esra ERGÜL
Emine Esra ERGÜL
MMMeltem Alkan Melikoğlu
Meltem Alkan Melikoğlu
Objectives: The aim of this study was to compare the risk of falling in patients with rheumatoid arthritis (RA) to the healthy individuals and to identify the factors affecting the risk of falls. Patients and methods: Between December 2015 and August 2016, a total of 100 consecutive patients with RA (16 males, 84 females; mean age: 49.5±11.1 years; range, 21 to 65 years) and 50 healthy controls (11 males, 39 females; mean age: 34.3±12.7 years; range, 19 to 63 years) were included in this prospective study. The fall risk was evaluated using the Tetrax Portable Balance System. The Health Assessment Questionnaire Disability Index (HAQ-DI), RA disease activity (Disease Activity Score 28 [DAS28], Clinical Disease Activity Index [CDAI], and Simple Disease Activity Index [SDAI]), and Falls Efficacy Scale International (FES-I) were applied to all participants. Results: The fall risk scores and the FES-I scores were significantly higher in the patients with RA than the control group (p<0.001, p<0.001). A positive significant correlation was found between the Tetrax values of the patients and age, and the scores of the HAQ-DI, FES, DAS28, DAS28-C-reactive protein, CDAI and SDAI. Conclusion: Our study results showed higher fall risk scores in patients with RA than healthy individuals an objective computerized technique, and this higher fall risk appeared to be affected by older age, disease activity, and disability.


1 January 2025 in The Turkish Journal of Geriatrics
Verified
Journal Article
Closed access
Emine Esra ERGÜLEmine Esra ERGÜL
Emine Esra ERGÜL
EÖElif Can Özdemi̇r
Elif Can Özdemi̇r
HAHilal Büşra Ayçi̇çEk
Hilal Büşra Ayçi̇çEk
SHSerhat HAYME
Serhat HAYME
AKAysel Özge Kemer
Aysel Özge Kemer
GAGonca Sağlam Akkaya
Gonca Sağlam Akkaya
Introduction: Grip strength represents a critical, objective indicator of functional capacity in daily activities. This study sought to elucidate the impact of breast cancer-related lymphedema on grip strength and to explore the underlying factors contributing to its decline. Materials and method: This is a retrospective study including patients over the age of 65 who presented to our outpatient clinic after developing lymphedema following breast cancer treatment. Hand grip strength was measured using a hand dynamometer in patients with lymphedema, and data on lymphedema stage and clinical parameters were collected. Results: In older adults with lymphedema, grip strength was significantly reduced on the affected side (median: 8.0 kg [3–21]) compared to the nonaffected side (median: 16.5 kg [10–29]; p < 0.001). Patients with more advanced stages of lymphedema were found to have lower grip strength on the affected side compared to those with earlier stages. In older adults with lymphedema, grip strength was also correlated with the subscales of quality of life and with fatigue, both considered important clinical outcomes. Conclusion: Our findings highlight that lymphedema in older adults is associated with clear functional impairment, as evidenced by reduced grip strength on the affected side and a progressive decline across disease stages, underscoring the importance of early intervention to preserve hand function. Keywords: Lymphedema; Breast Neoplasms; Aged; Hand Strength.

6 August 2026 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
PDF file
Emine Esra ERGÜLEmine Esra ERGÜL
Emine Esra ERGÜL
BEBilge Ekinci
Bilge Ekinci
SHSerhat Hayme
Serhat Hayme
The impact of hand grip strength on quality of life, fatigue, physical performance, and functional capacity in patients with post-mastectomy lymphedema - Turkish Journal of Physical Medicine and Rehabilitation

12 January 2026 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
PDF file
Emine Esra ERGÜLEmine Esra ERGÜL
Emine Esra ERGÜL
OLOğuzhan Laçin
Oğuzhan Laçin
HKHamide Özge Kılıçaslan
Hamide Özge Kılıçaslan
FBFahrettin Bostancı
Fahrettin Bostancı
EÖElif Can Özdemir
Elif Can Özdemir
HAHilal Büşra Ayçiçek
Hilal Büşra Ayçiçek
Background: The aim of this study is to evaluate the risk of osteonecrosis of the jaw in patients receiving osteoporosis treatment using C-terminal cross-linked telopeptide of type 1 collagen (CTX-1) values, to analyze follow-ups after drug holidays, and to compare treatment agents and other risk factors to determine the association with CTX-1 results. Methods: A total of 273 patients (266 female and 7 male) who received bisphosphonate and denosumab treatment for osteoporosis were included in this retrospective study. Sociodemographic characteristics, vitamin D levels, serum CTX-1 level, presence of diseases affecting CTX-1 levels, type of bisphosphonate, duration of use, presence of drug holidays, and duration of denosumab use (if any) were recorded. The effects of bisphosphonates and denosumab on CTX-1 levels were compared, and differences in the risk of osteonecrosis between them were evaluated. Results: In this study, a meaningful association was not identified between serum CTX-1 levels and the measured vitamin D values (P = .232). Patients who underwent a drug holiday had significantly higher mean serum CTX-1 levels (266.2 Å} 175.1 pg/mL) compared to those without a drug holiday (199.9 Å} 138.5 pg/ mL; P = .009). Higher CTX-1 levels were observed in individuals receiving ibandronate and alendronate, whereas the lowest values were detected in patients treated with denosumab. Conclusion: Serum CTX-1 levels appeared unaffected by vitamin D. Although the denosumab group exhibited the highest risk of osteonecrosis, the difference compared to zoledronic acid was not statistically significant. These results suggest caution during jaw-related procedures and consideration of drug holidays when necessary. Cite this article as: Ergül EE, Laçin O, Kılıçaslan HÖ, et al. Evaluation of osteonecrosis risk using serum C-terminal cross-linked telopeptide of type 1 collagen (CTX-1) levels in osteoporotic patients: Effects of drug holidays and risk factors. Eurasian J Med. 2026, 58(1), 1104, doi:10.5152/eurasianjmed.2026.251104.